EF

Erik Fenster

TI Theravance Biopharma R&D Ip: 5 patents #5 of 35Top 15%
📍 San Bruno, CA: #4 of 86 inventorsTop 5%
🗺 California: #3,807 of 60,394 inventorsTop 7%
Overall (2017): #31,641 of 506,227Top 7%
5
Patents 2017

Issued Patents 2017

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
9840460 Neprilysin inhibitors Melissa Fleury, Adam D. Hughes 2017-12-12
9688616 Neprilysin inhibitors Melissa Fleury, Adam D. Hughes 2017-06-27
9682052 Neprilysin inhibitors Adam D. Hughes, Melissa Fleury, Roland Gendron, Edmund J. Moran 2017-06-20
9670143 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid Adam D. Hughes, Melissa Fleury, Anne-Marie Beausoleil, Venkat R. Thalladi, Jerry Nzerem +1 more 2017-06-06
9533962 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Venkat R. Thalladi, Miroslav Rapta 2017-01-03